MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy. [PDF]
J Exp Clin Cancer Res, 2020 Yao HP, Tong XM, Hudson R, Wang MH.
europepmc +1 more source
Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration. [PDF]
Transl Oncol, 2011 Gunes Z +14 more
europepmc +1 more source
The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies. [PDF]
Pancreas, 2014 Kang CM, Babicky ML, Lowy AM.
europepmc +1 more source
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence. [PDF]
Cell Commun SignalWu K +9 more
europepmc +1 more source
Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy. [PDF]
Acta Pharmacol Sin, 2010 Wang MH +4 more
europepmc +1 more source
Emerging antibody combinations in oncology. [PDF]
MAbs, 2011 Demarest SJ, Hariharan K, Dong J.
europepmc +1 more source
Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma. [PDF]
Br J Cancer, 2013 Keller J +8 more
europepmc +1 more source
Transmission of Calicophoron daubneyi and Fasciola hepatica in Galicia (Spain): Temporal follow-up in the intermediate and definitive hosts. [PDF]
Parasit Vectors, 2016 Iglesias-Piñeiro J +6 more
europepmc +1 more source
Part 3. Triethylborane-air: a suitable initiator for intermolecular radical additions of S-2-oxoalkyl-thionocarbonates (S-xanthates) to olefins. [PDF]
Beilstein J Org Chem, 2007 Boivin J, Nguyen VT.
europepmc +1 more source
Essential loci in centromeric heterochromatin of Drosophila melanogaster. I: the right arm of chromosome 2. [PDF]
Genetics, 2010 Coulthard AB +7 more
europepmc +1 more source